CD86 polymorphism affects pneumonia-induced sepsis by decreasing gene expression in monocytes

Area of Science:

• Immunogenetics
• Molecular Biology
• Clinical Medicine

Background:

• Sepsis is a major global health concern, leading to significant morbidity and mortality.
• CD86 (B7-2) is a crucial costimulatory molecule in immune responses, expressed on antigen-presenting cells.
• Understanding genetic factors influencing sepsis susceptibility is vital for developing targeted interventions.

Purpose of the Study:

• To investigate the association between CD86 gene polymorphisms (rs1129055G/A and rs17281995G/C) and pneumonia-induced sepsis susceptibility.
• To examine the impact of these CD86 polymorphisms on CD86 gene expression in monocytes.

Main Methods:

• Genotyping of CD86 polymorphisms rs1129055G/A and rs17281995G/C in 192 pneumonia-induced septic patients and 201 healthy controls.
• Analysis of CD86 messenger RNA (mRNA) and protein expression levels in monocytes.
• Statistical analysis including odds ratios (OR) and confidence intervals (CI).

Main Results:

• The CD86 rs1129055G/A polymorphism showed decreased frequencies in septic patients, suggesting a protective effect.
• Conversely, the CD86 rs17281995G/C polymorphism was significantly more frequent in pneumonia-induced sepsis patients.
• Monocytes from healthy individuals with the rs17281995GC genotype exhibited downregulated CD86 mRNA and protein levels compared to wild-type (GG).

Conclusions:

• CD86 gene polymorphisms exert varied effects on the pathogenesis of pneumonia-induced sepsis.
• The rs17281995G/C polymorphism appears to elevate the risk of pneumonia-induced sepsis, potentially by impairing CD86 gene expression in monocytes.